PHCentral RSS - rss FIRE feed Tue, 9 Feb 2016 01:02:46 GMT Subjective loss of performance after pulmonary embolism in an athlete– beyond normal values February 14, 2016 Reversal of MicroRNA Dysregulation in an Animal Model of Pulmonary Hypertension February 13, 2016 Sex disparities in systemic sclerosis-associated pulmonary arterial hypertension: a cohort study February 12, 2016 Medical Mondays: CTEPH February 11, 2016 The Right Ventricle: A Not-So-Innocent Bystander in Pulmonary Hypertension Due to Left Heart Disease February 10, 2016 High Frequency of Pulmonary Hypertension-Causing Gene Mutation in Chinese Patients with Chronic Thromboembolic Pulmonary Hypertension February 9, 2016 Ambrisentan avoids sildenafil drug interaction in PAH patients February 8, 2016 Overview of WHO Group 2 Pulmonary Hypertension Due to Left Heart Disease February 8, 2016 PAH Patients with BMPR2 Mutations Likely to Have Severe Disease Progression February 7, 2016 Actelion receives positive CHMP opinion for Uptravi (selexipag) for the long-term treatment of PAH February 6, 2016 PAH Oral Prostacyclin Analog Drugs, Like Treprostinil, Are Improving But Have Way to Go February 5, 2016 Transfemoral TAVR shows reductions in mortality, paravalvular leak{e3de2e14-5c5d-472b-852c-620f2f0c9145}/transfemoral-tavr-shows-reductions-in-mortality-paravalvular-leak February 3, 2016 When patients and drug makers align on a cause, whose best interests are at play? February 2, 2016 Fiber-Rich Diet May Boost Lung Function February 1, 2016 A case of a patient with pulmonary hypertension associated with multiple endocrine dysfunctions and connective tissue disorder January 31, 2016 Peripheral pulmonary artery stenosis as a cause of pulmonary hypertension in adults January 30, 2016 Incident pulmonary arterial hypertension associated with greater risk for disease progression{0688afe7-3c86-4c33-80f0-6a21f4f0b655}/incident-pulmonary-arterial-hypertension-associated-with-greater-risk-for-disease-progression January 29, 2016 New Metabolites Associated With Hemodynamic Indicators of Right Ventricular-Pulmonary Vascular Dysfunction Discovered January 29, 2016 Journal of American College of Cardiology.]]> BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis January 28, 2016 Pulmonary Hypertension Often Missed in its Early Stages January 27, 2016 Actelion receives Health Canada approval for Uptravi January 26, 2016 £1.5m to back Cambridge firm developing revolutionary treatment for respiratory condition January 26, 2016 CardioBrief: Why Guidelines Are Bad for Science January 24, 2016 Editors Deliver Major Victory to Open Data Movement January 23, 2016
"This is a remarkable day; the medical editors showed leadership in demonstrating that we medical scientists must put the interests of society first. There are a lot of details to work out -- but they have given substantial impetus to the open science movement and to the efforts to have medical research be transparent. If this proposal is accepted, then the medical science world will be forever transformed for the better."]]>
Potentially transformative therapy for rare heart disease to be progressed by Morphogen-IX January 22, 2016 Lupus affects lungs, leads to pleuritis, pneumonitis and pulmonary hypertension January 21, 2016 Lung cell found to act as sensor, regulator of immune response January 20, 2016 Formulation scientists to rescue patients with pulmonary arterial hypertension January 19, 2016 Video Feature: Idiopathic Pulmonary Fibrosis January 18, 2016 Therapeutic Potential of microRNA Modulation in PulmonaryArterialHypertension January 17, 2016 Pulmonary Hypertension January 16, 2016 Genetic counselling in a national referral centre for pulmonary hypertension. January 15, 2016 BETA-3 Adrenoceptor Agonists for the Treatment of Pulmonary Hypertension January 14, 2016 Left ventricular diastolic dysfunction in PH predicts functional capacity and clinical worsening: a tissue phase mapping study January 13, 2016 Assessment of Thyroid Function in Idiopathic Pulmonary Hypertension January 12, 2016 Bedfont Scientific establishes NoxBOX subsidiary January 11, 2016
iNO therapy is mainly used in intensive care units (ICU) to aid in the therapeutic care of premature babies and patients under severe respiratory distress. Using iNO therapy allows the blood supply to pick up oxygen from the lungs more readily by dilating the pulmonary arteries, making it the ideal method of treatment for pulmonary hypertension and other conditions that can lead to severe breathing difficulties.]]>
Tips to ease the journey when traveling with portable medical devices needing power January 10, 2016